Ticker: NXEN

Nexien BioPharma, Inc. (PINK: NXEN) has reported its financial results for the period ending March 31, 2025, revealing critical insights into its operations and financial health. Key Financial Highlights: Net Loss: The company reported a net loss of $30,092 for Q3 2025 compared to a loss of $53,...